for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Merck to buy $1 billion equity stake in Seattle Genetics

Sept 14 (Reuters) - Merck & Co Inc said on Monday it would buy $1 billion worth of equity stake in Seattle Genetics’s common stock.

The companies also said they would co-develop and sell Seattle Genetics's cancer therapy, ladiratuzumab vedotin. ( reut.rs/3bWTEvS) (Reporting by Trisha Roy in Bengaluru; Editing by Rashmi Aich)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up